McKesson Stock
McKesson Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Country
- United States
- CEO
- Brian S. Tyler
- Employees
- 42,300
- Market cap
- $117.2 B
- IPO
- 10/11/1994
McKesson Corporation is a prominent global provider of healthcare services headquartered in Irving, Texas. Founded in 1833, the company operates extensively across both United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
McKesson stock: price history
1D
+0.6%
1W
+7.0%
1M
+13.2%
6M
+16.0%
YTD
+22.5%
1Y
+29.6%
2Y
+96.7%
5Y
+392.2%
10Y
+524.1%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~55% stronger price swings than usual
McKesson stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 16/10/2026.
Business model & megatrends
Average business model without a clear megatrend link or with mixed signals.
3 more assignments (Enabler/Second row) Pro-only.
McKesson Corporation is an international provider of healthcare services with a primary focus on large-scale distribution of pharmaceuticals. The company distributes a broad portfolio of products ranging from branded and generic medications to specialty pharmaceuticals and medical consumables. Beyond physical product distribution, McKesson offers specialized services including practice management tools for oncology practices, software solutions to optimize medication adherence, and logistics services for the pharmaceutical industry. Through this integration of distribution and technological solutions, the company supports stakeholders across the entire supply chain, from biopharmaceutical partners to pharmacies and healthcare providers.
- Revenue model
- Hardware sales
- Recurring revenue
- Low
- Pricing power
- Weak
- Moat
- Narrow
- Moat type
- Network effects
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about McKesson
Analyst assessment of McKesson
PRICE TARGET LOW
US$845.00
CONSENSUS
US$977.86
MEDIAN
US$977.00
PRICE TARGET HIGH
US$1,200.00
1
STRONG BUY
24
BUY
6
HOLD
0
SELL
0
STRONG SELL
31
TOTAL · Buy
As of: 16/10/2026
McKesson stock metrics
P/E
26.77
P/B
-28.13
EV/EBITDA
16.85
RETURN ON EQUITY
-14.5%
NET MARGIN
0.6%
DEBT/EQUITY
-2.76
DIVIDEND YIELD
0.3%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.9%
FLOAT SHARES
116,515,149
AVG. DAILY VOLUME (30D)
816,149
Insider transactions (SEC)
Rutledge Napoleon B JR
Lerman Bradley E
Wilson-Thompson Kathleen
Martinez Maria
Caruso Dominic J
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.6%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about McKesson stock
What does McKesson do?
McKesson Corporation is a company in the Healthcare sector, Medical - Distribution industry, headquartered in United States.
The CEO is Brian S. Tyler, the company employs around 42,300 people.
The IPO was on 10/11/1994; the stock trades on NYSE under the ticker MCK.
What do analysts say about McKesson stock?
31 analysts rate the stock, the consensus is Buy (as of 16/10/2026).
The average price target is US$977.86, ranging from US$845.00 to US$1,200.00, with a median of US$977.00.
This is an external assessment, not a statement by Market Jury.
When does McKesson report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 55% stronger than usual.
Does McKesson pay a dividend?
Yes. The last dividend was US$0.94 per share, ex-date 01/09/2026, paid on 01/10/2026.
The dividend yield is 0.3% (as of 30/06/2026).
Which stocks are comparable to McKesson?
Comparable stocks include Cencora, Cardinal Health, Henry Schein, DocMorris, Eli Lilly and Company, Johnson & Johnson, AbbVie and Merck &.
How can I get McKesson stock analyzed?
Clicking "Analyze stock" lets five strategies assess McKesson against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.